Synergistic Herbal-Allopathic Pain Management

Authors

  • Ankita V. Chavan Department of Pharmacology, Ashokrao Mane Institute of Pharmacy Ambap, Wathar 416112, Maharashtra, India. Author
  • Anuja D. Nirwane Department of Pharmacology, Ashokrao Mane Institute of Pharmacy Ambap, Wathar 416112, Maharashtra, India. Author
  • Anuja C. Khatale Department of Pharmacology, Ashokrao Mane Institute of Pharmacy Ambap, Wathar 416112, Maharashtra, India. Author
  • Sneha D. Patil Department of Pharmacology, Ashokrao Mane Institute of Pharmacy Ambap, Wathar 416112, Maharashtra, India. Author
  • Dr. Nilesh B. Chougule Department of Pharmacology, Ashokrao Mane Institute of Pharmacy Ambap, Wathar 416112, Maharashtra, India. Author

Keywords:

Analgesic activity, Anti-inflammatory, Herbal allopathic combination, Herbs.\

Abstract

Background: Combining herbal medicine with allopathic analgesics has drawn interest as a way to enhance the results of pain treatment. Products made from herbs have very few or no negative effects, improving quality of life. Objective: In order to enhance pain relief while reducing side effects, this study aims to create and assess a unique synergistic formulation that blends particular plant extracts with a conventional allopathic painkiller. Methods: This study intends to develop and evaluate a novel synergistic formulation that combines specific plant extracts with a traditional allopathic painkiller to improve pain relief while minimizing side effects. Results: This review facilitates comprehension of the particulars of analgesic properties. It shows that a safe and practical choice for efficient pain relief is a herbal-allopathic combo treatment. Discussion: Complementary routes are used in synergistic herbal-allopathic combos to achieve greater efficacy. By suppressing NF-κB and improving opioid receptor modulation, gingerols reduce GI toxicity and allow for a 40–50% dose reduction. When coupled with NSAIDs, turmeric's curcumin exhibits comparable acute analgesia but outperforms ginger in chronic inflammation due to its strong COX-2/PGE2 inhibition (IC50 10 μM) (Fig. 2-3 merged). In all MIA/CCI models, these interactions provide combination indices <0.7, indicating increased safety and therapeutic synergy. Conclusion: By using the synergistic effects of both natural and synthetic chemicals, this method offers a fresh way to address the limitations of single-drug treatments and meet the varied needs of pain sufferers.

Downloads

Published

2026-09-09